550 related articles for article (PubMed ID: 15659147)
1. Refractory acute kidney transplant rejection with CD20 graft infiltrates and successful therapy with rituximab.
Alausa M; Almagro U; Siddiqi N; Zuiderweg R; Medipalli R; Hariharan S
Clin Transplant; 2005 Feb; 19(1):137-40. PubMed ID: 15659147
[TBL] [Abstract][Full Text] [Related]
2. B cells in cluster or in a scattered pattern do not correlate with clinical outcome of renal allograft rejection.
Scheepstra C; Bemelman FJ; van der Loos C; Rowshani AT; van Donselaar-Van der Pant KA; Idu MM; ten Berge IJ; Florquin S
Transplantation; 2008 Sep; 86(6):772-8. PubMed ID: 18813100
[TBL] [Abstract][Full Text] [Related]
3. Failure of anti-CD20 monoclonal antibody therapy to prevent antibody-mediated rejection in three crossmatch-positive renal transplant recipients.
Matignon M; Tagnaouti M; Audard V; Dahan K; Lang P; Grimbert P
Transplant Proc; 2007 Oct; 39(8):2565-7. PubMed ID: 17954175
[TBL] [Abstract][Full Text] [Related]
4. ABO-incompatible live donor renal transplantation using blood group A/B carbohydrate antigen immunoadsorption and anti-CD20 antibody treatment.
Nordén G; Briggs D; Cockwell P; Lipkin G; Mjörnstedt L; Mölne J; Ready A; Rydberg L; Samuelsson O; Svalander CT; Breimer ME
Xenotransplantation; 2006 Mar; 13(2):148-53. PubMed ID: 16623810
[TBL] [Abstract][Full Text] [Related]
5. Detection of B lymphocytes (CD20+) in renal allograft biopsy specimens.
Martins HL; Silva C; Martini D; Noronha IL
Transplant Proc; 2007 Mar; 39(2):432-4. PubMed ID: 17362749
[TBL] [Abstract][Full Text] [Related]
6. Rituximab removes intrarenal B cell clusters in patients with renal vascular allograft rejection.
Steinmetz OM; Lange-Hüsken F; Turner JE; Vernauer A; Helmchen U; Stahl RA; Thaiss F; Panzer U
Transplantation; 2007 Oct; 84(7):842-50. PubMed ID: 17984836
[TBL] [Abstract][Full Text] [Related]
7. Impact of rituximab therapy for treatment of acute humoral rejection.
Kaposztas Z; Podder H; Mauiyyedi S; Illoh O; Kerman R; Reyes M; Pollard V; Kahan BD
Clin Transplant; 2009; 23(1):63-73. PubMed ID: 19200217
[TBL] [Abstract][Full Text] [Related]
8. CD20+ lymphocytes in renal allografts are associated with poor graft survival in pediatric patients.
Tsai EW; Rianthavorn P; Gjertson DW; Wallace WD; Reed EF; Ettenger RB
Transplantation; 2006 Dec; 82(12):1769-73. PubMed ID: 17198274
[TBL] [Abstract][Full Text] [Related]
9. Dense B cell infiltrates in paediatric renal transplant biopsies are predictive of allograft loss.
Muorah MR; Brogan PA; Sebire NJ; Trompeter RS; Marks SD
Pediatr Transplant; 2009 Mar; 13(2):217-22. PubMed ID: 18433412
[TBL] [Abstract][Full Text] [Related]
10. Late humoral rejection in a cardiac transplant recipient treated with the anti-CD20 monoclonal antibody rituximab.
Keren A; Hayes HM; O'Driscoll G
Transplant Proc; 2006 Jun; 38(5):1520-2. PubMed ID: 16797348
[TBL] [Abstract][Full Text] [Related]
11. BAFF may modulate the rate of B-cell repopulation after rituximab therapy for acute renal transplant rejection.
Zarkhin V; Li L; Sarwal MM
Transplantation; 2009 Nov; 88(10):1229-30. PubMed ID: 19935379
[No Abstract] [Full Text] [Related]
12. The presence of B-cell nodules does not necessarily portend a less favorable outcome to therapy in patients with acute cellular rejection of a renal allograft.
Doria C; di Francesco F; Ramirez CB; Frank A; Iaria M; Francos G; Marino IR; Farber JL
Transplant Proc; 2006 Dec; 38(10):3441-4. PubMed ID: 17175297
[TBL] [Abstract][Full Text] [Related]
13. Successful management of antibody-mediated cardiac allograft rejection with combined immunoadsorption and anti-CD20 monoclonal antibody treatment: case report and literature review.
Kaczmarek I; Deutsch MA; Sadoni S; Brenner P; Schmauss D; Daebritz SH; Weiss M; Meiser BM; Reichart B
J Heart Lung Transplant; 2007 May; 26(5):511-5. PubMed ID: 17449422
[TBL] [Abstract][Full Text] [Related]
14. Refractory CD20 Positive Cellular Rejection in Living Kidney Transplant: A Case Report and Review of Literature.
Akl AI; Sheashaa HA; Rahim MA; El Hadedy MA; Refaie AF
Exp Clin Transplant; 2019 Dec; 17(6):823-827. PubMed ID: 29534659
[TBL] [Abstract][Full Text] [Related]
15. Minimization of immunosuppressive therapy and immunological monitoring of kidney transplant recipients with long-term allograft survival.
Pretagostini R; Cinti P; Lai Q; Poli L; Berloco PB
Transpl Immunol; 2008 Nov; 20(1-2):3-5. PubMed ID: 18773959
[TBL] [Abstract][Full Text] [Related]
16. Tacrolimus rescue therapy for corticosteroid-resistant and polyclonal antibody-resistant kidney allograft rejections.
Naderi GH; Mehraban D; Ganji MR; Yahyazadeh SR; Latif AH
Urol J; 2009; 6(1):31-4. PubMed ID: 19241339
[TBL] [Abstract][Full Text] [Related]
17. OKT3 treatment for steroid-resistant acute rejection in kidney transplantation.
Sevmis S; Emiroglu R; Karakayali F; Yagmurdur MC; Dalgic A; Moray G; Haberal M
Transplant Proc; 2005 Sep; 37(7):3016-8. PubMed ID: 16213290
[TBL] [Abstract][Full Text] [Related]
18. Anaphylaxis and desensitization to the murine monoclonal antibody used for renal graft rejection.
Georgitis JW; Browning MC; Steiner D; Lorentz WB
Ann Allergy; 1991 Apr; 66(4):343-7. PubMed ID: 1901692
[TBL] [Abstract][Full Text] [Related]
19. Human mouse chimeric CD7 monoclonal antibody (SDZCHH380) for the prophylaxis of kidney transplant rejection.
Lazarovits AI; Rochon J; Banks L; Hollomby DJ; Muirhead N; Jevnikar AM; White MJ; Amlot PL; Beauregard-Zollinger L; Stiller CR
Transplant Proc; 1993 Feb; 25(1 Pt 1):820-2. PubMed ID: 7679844
[No Abstract] [Full Text] [Related]
20. Rituximab and intravenous immunoglobulin treatment of chronic antibody-mediated kidney allograft rejection.
Fehr T; Rüsi B; Fischer A; Hopfer H; Wüthrich RP; Gaspert A
Transplantation; 2009 Jun; 87(12):1837-41. PubMed ID: 19543061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
